Company facts
- Industry
- Hospital & Medical Service Plans
- Headquarters
- Indianapolis, Indiana
- Most recent report
- 10-Q, filed Oct 21, 2026
- Incorporated
- Indiana
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1156039
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 53
News 8 of 166
- 8-K Quarterly results Oct 21, 2026
- 8-K Current report on a material event Sep 10, 2026
- 8-K Quarterly results Jul 15, 2026
- 8-K Current report on a material event Jun 10, 2026
- 8-K Shareholder vote results May 13, 2026
- 8-K Quarterly results Apr 22, 2026
- 8-K Current report on a material event Mar 10, 2026
- 8-K Other events Mar 2, 2026
Prospectuses and Registrations 8 of 50
- S-3ASR Automatic shelf registration Oct 28, 2026
- 424B3 Prospectus supplement for an offering Sep 9, 2025
- FWP Free writing prospectus Sep 8, 2025
- 424B3 Prospectus supplement for an offering Sep 8, 2025
- 424B3 Prospectus supplement for an offering Oct 23, 2024
- FWP Free writing prospectus Oct 22, 2024
- 424B3 Prospectus supplement for an offering Oct 22, 2024
- 424B3 Prospectus supplement for an offering May 21, 2024
Proxies 8 of 39
- PX14A6G Shareholder's own proxy material Apr 7, 2026
- DEFA14A Extra proxy material Mar 27, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 27, 2026
- PX14A6G Shareholder's own proxy material Apr 14, 2025
- DEFA14A Extra proxy material Mar 28, 2025
- DEFA14A Extra proxy material Mar 28, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 28, 2025
- DEFA14A Extra proxy material Apr 22, 2024
Ownership 8 of 601
- 4 Insider reported a trade Nov 6, 2026
- 144 Notice of a proposed sale of restricted stock Nov 5, 2026
- 4 Insider reported a trade Oct 23, 2026
- 144 Notice of a proposed sale of restricted stock Oct 22, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Sep 4, 2026
- 4 Insider reported a trade Sep 4, 2026
- 4 Insider reported a trade Jul 17, 2026
Other 8 of 92
- 11-K Employee stock plan report Jun 17, 2026
- 11-K Employee stock plan report Jun 17, 2026
- 11-K Employee stock plan report Jun 24, 2025
- 11-K Employee stock plan report Jun 24, 2025
- 11-K Employee stock plan report Jun 20, 2024
- 11-K Employee stock plan report Jun 22, 2023
- 11-K Employee stock plan report Jun 24, 2022
- 11-K Employee stock plan report Jun 29, 2021
What to read: Sep 2026 10-Q
SECSift found 2 of 13 sections worth reading, with 1 positive, 3 notable, and 6 negative flags.
Financial Statements (Item 1)
Multiple concerns: earnings decline, CMS accrual, litigation, large off-balance-sheet derivatives.NotableNegative- Net put option on Mosaic Health of $1,330 million in noncurrent liabilities, not marked to market.
- Effective tax rate spiked to 25.1% in Q3 2026 from 15.6% in Q3 2025 due to fewer tax credits.
- CMS risk adjustment accrual: $935M recorded, $342 paid, $593 liability remains at Sep 30, 2026.
- IDR matters: $669M liabilities recorded, potential additional $324M possible.
- Securities class action: court denied motion to dismiss, allowing claims to proceed.
Management's Discussion (Item 2)
MD&A reveals core business deterioration in Health Benefits segment and Medicare Advantage.
What changed: Sep 2026 vs. Jun 2026
About 4% of ELV's Sep 2026 10-Q is new information. 17 paragraphs were added, 174 changed, and 30 removed. Below are the most important lines SECSift identified.
New
- Q3 2026: operating revenue $50,440, net income $1,365, EPS $6.27. Nine months: revenue $149,760, net income $4,592, EPS $21.01.
- Newly disclosed $669 in liabilities for No Surprises Act IDR disputes, with $575 in self-funded receivables, as of September 30, 2026.
- Added May 2026 final IDR regulations, May 2026 NBPP, June 2026 court vacating Marketplace rule. Removed paragraph on ACA continuing to impact business.
- Newly disclosed federal securities class action and derivative lawsuits filed in May 2025; court denied motion to dismiss in September 2026.
Changed
- Accumulated other comprehensive loss grew to $1,676 from $711 at June 30, 2026, a $965 increase.
- Remaining buyback authority dropped to $5,007 million from $5,337 million.
- Employee withholding shares fell to 2,340 from 10,080.
- New five-year CVS agreement from Jan 1, 2027 to Dec 31, 2031; prior term through Dec 2027 with three-year extension.
- Replaced the prior CVS agreement (through 2027 with extension) with a new five-year agreement from January 1, 2027 to December 31, 2031.
Everything here comes from Elevance Health, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Oct 21, 2026, from the 10-Q for Sep 2026.